{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:01:04Z","timestamp":1784095264402,"version":"3.55.0"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:00:00Z","timestamp":1648598400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jneuroim.2022.577849","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T20:49:00Z","timestamp":1648241340000},"page":"577849","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Inflammatory profiles in plasma and cerebrospinal fluid of patients with neurosarcoidosis"],"prefix":"10.1016","volume":"367","author":[{"given":"Keld-Erik","family":"Byg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsolt","family":"Illes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Sejbaek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate L.","family":"Lambertsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torkell","family":"Ellingsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helle H.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2022.577849_bb0005","doi-asserted-by":"crossref","DOI":"10.1111\/aos.13835","article-title":"The CC chemokines CCL8, CCL13 and CCL20 are local inflammatory biomarkers of HLA-B27-associated uveitis","volume":"97","author":"Abu El-Asrar","year":"2019","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0010","first-page":"160","author":"American Thoracic Society","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0015","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1378\/chest.130.4.982","article-title":"Different angiogenic activity in pulmonary sarcoidosis and idiopathic pulmonary fibrosis","volume":"130","author":"Antoniou","year":"2006","journal-title":"Chest."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0020","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3389\/fimmu.2020.01129","article-title":"T-bet expression in peripheral Th17.0 cells is associated with pulmonary function changes in sarcoidosis","volume":"11","author":"Arger","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0025","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1365-2249.1997.492-ce1389.x","article-title":"An assessment of peripheral immunity in patients with sarcoidosis using measurements of serum vitamin D3, cytokines and soluble CD23","volume":"110","author":"Bansal","year":"1997","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0030","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.rmed.2010.12.010","article-title":"Analysis of serum amyloid A in sarcoidosis patients","volume":"105","author":"Bargagli","year":"2011","journal-title":"Respir. Med."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0035","article-title":"ERS clinical practice guidelines on treatment of sarcoidosis","volume":"2004079","author":"Baughman","year":"2021","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/cells10030585","article-title":"Elevated serum amyloid A levels are not specific for sarcoidosis but associate with a fibrotic pulmonary phenotype","volume":"10","author":"Beijer","year":"2021","journal-title":"Cells."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0045","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1183\/09031936.00028209","article-title":"Multiplex immune serum biomarker profiling in sarcoidosis and systemic sclerosis","volume":"34","author":"Beirne","year":"2009","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0050","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1365-2796.1998.00378.x","article-title":"The lymphocytic alveolitis in sarcoidosis is associated with increased amounts of soluble and cell-bound adhesion molecules in bronchoalveolar lavage fluid and serum","volume":"244","author":"Berlin","year":"1998","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci11020238","article-title":"Elevated neurofilament light chain in cerebrospinal fluid and plasma reflect inflammatory MRI activity in neurosarcoidosis","volume":"11","author":"Byg","year":"2021","journal-title":"Brain Sci."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0060","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1164\/ajrccm.165.2.2106084","article-title":"Increased macrophage inflammatory protein-1alpha and macrophage inflammatory protein-1beta levels in bronchoalveolar lavage fluid of patients affected by different stages of pulmonary sarcoidosis","volume":"165","author":"Capelli","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0065","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1164\/ajrccm.149.3.8118632","article-title":"Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis","volume":"149","author":"Car","year":"1994","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0070","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/apm.12740","article-title":"CCL2 recruits T cells into the brain in a CCR2-independent manner","volume":"125","author":"C\u00e9dile","year":"2017","journal-title":"APMIS."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0075","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1111\/ene.13975","article-title":"The cerebrospinal fluid CD4\/CD8 ratio and interleukin-6 and -10 levels in neurosarcoidosis: a multicenter, pragmatic, comparative study","volume":"26","author":"Chazal","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0080","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1164\/rccm.200905-0696OC","article-title":"Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2","volume":"181","author":"Chen","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0085","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00415-017-8444-9","article-title":"Long-term outcomes of refractory neurosarcoidosis treated with infliximab","volume":"264","author":"Cohen Aubart","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0090","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte chemoattractant protein-1 (MCP-1): an overview","volume":"29","author":"Deshmane","year":"2009","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0095","first-page":"91","article-title":"Practical eminence and experience-based recommendations for use of TNF-\u03b1 inhibitors in sarcoidosis","volume":"31","author":"Drent","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0100","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJMoa1602773","article-title":"Ustekinumab as induction and maintenance therapy for Crohn\u2019s disease","volume":"375","author":"Feagan","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0105","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1183\/09031936.03.00083002","article-title":"Alveolar macrophages are the main source for tumour necrosis factor-alpha in patients with sarcoidosis","volume":"21","author":"Fehrenbach","year":"2003","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0110","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1212\/WNL.0000000000004644","article-title":"Infliximab for the treatment of CNS sarcoidosis: a multi-institutional series","volume":"89","author":"Gelfand","year":"2017","journal-title":"Neurology."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0115","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.cyto.2013.07.010","article-title":"Plasma level of interferon \u03b3 induced protein 10 is a marker of sarcoidosis disease activity","volume":"64","author":"Geyer","year":"2013","journal-title":"Cytokine."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.585880","article-title":"Tumor necrosis factor receptors: pleiotropic signaling complexes and their differential effects","volume":"11","author":"Gough","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0125","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-019-0096-x","article-title":"Sarcoidosis","volume":"5","author":"Grunewald","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jneuroim.2022.577849_bb0130","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1046\/j.1365-2249.1998.00519.x","article-title":"Correlation of plasma monocyte chemoattractant protein-1 (MCP-1) and monocyte inflammatory protein-1alpha (MIP-1alpha) levels with disease activity and clinical course of sarcoidosis","volume":"111","author":"Hashimoto","year":"1998","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0135","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.2169\/internalmedicine.46.6278","article-title":"Circulating IL-12 p40 is increased in the patients with sarcoidosis, correlation with clinical markers","volume":"46","author":"Hata","year":"2007","journal-title":"Intern. Med."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0140","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0022-510X(69)90086-0","article-title":"Sarcoidosis of the central nervous system","volume":"9","author":"Herring","year":"1969","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0145","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1126\/science.8097338","article-title":"Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages","volume":"260","author":"Hsieh","year":"1993","journal-title":"Science."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0150","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2249.2008.03609.x","article-title":"Analysis of regulatory T cell associated forkhead box P3 expression in the lungs of patients with sarcoidosis","volume":"152","author":"Idali","year":"2008","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0155","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1378\/chest.107.6.1636","article-title":"Elevated levels of soluble ICAM-1 in serum and BAL fluid in patients with active sarcoidosis","volume":"107","author":"Ishii","year":"1995","journal-title":"Chest."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0160","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1007\/s00415-018-9001-x","article-title":"Clinical, imaging, and histological presentations and outcomes of stroke related to sarcoidosis","volume":"265","author":"Jachiet","year":"2018","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0165","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1183\/09031936.00000914","article-title":"Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis","volume":"44","author":"Judson","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0170","first-page":"19","article-title":"The WASOG Sarcoidosis Organ Assessment Instrument: an update of a previous clinical tool","volume":"31","author":"Judson","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0175","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.rmed.2006.06.004","article-title":"Tumor necrosis factor receptors (TNFRs) on T lymphocytes and soluble TNFRs in different clinical courses of sarcoidosis","volume":"101","author":"Kieszko","year":"2007","journal-title":"Respir. Med."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0180","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1378\/chest.115.4.1059","article-title":"Value of ICAM-1 expression and soluble ICAM-1 level as a marker of activity in sarcoidosis","volume":"115","author":"Kim","year":"1999","journal-title":"Chest."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0185","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1365-2133.2012.10901.x","article-title":"Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 years","volume":"166","author":"Kimball","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0190","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0092-8674(89)90676-4","article-title":"The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection","volume":"56","author":"Kindler","year":"1989","journal-title":"Cell."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0195","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nrneurol.2016.88","article-title":"Vascular endothelial growth factor: a neurovascular target in neurological diseases","volume":"12","author":"Lange","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0200","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12974-019-1601-6","article-title":"Cytokine and immune cell profiling in the cerebrospinal fluid of patients with neuro-inflammatory diseases","volume":"16","author":"Lepennetier","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2022.577849_bb0205","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1002\/eji.201040539","article-title":"IFN-\u03b3 and IL-12 synergize to convert in vivo generated Th17 into Th1\/Th17 cells","volume":"40","author":"Lexberg","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0210","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01160-2020","article-title":"Clinical phenotypes of extrapulmonary sarcoidosis: an analysis of a French, multi-ethnic, multicentre cohort","volume":"57","author":"Lhote","year":"2021","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0215","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1128\/CVI.00337-10","article-title":"Inflammatory profile and response to anti-tumor necrosis factor therapy in patients with chronic pulmonary sarcoidosis","volume":"18","author":"Loza","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0220","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1523\/JNEUROSCI.0211-16.2016","article-title":"Oligodendroglial TNFR2 mediates membrane TNF-dependent repair in experimental autoimmune encephalomyelitis by promoting oligodendrocyte differentiation and remyelination","volume":"36","author":"Madsen","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0225","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/jnnp.58.5.548","article-title":"Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Beh\u00e7et\u2019s disease involving the nervous system","volume":"58","author":"McLean","year":"1995","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2022.577849_bb0230","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/00365519950185805","article-title":"Age-related reference intervals for lymphocyte subsets in whole blood of healthy individuals","volume":"59","author":"McNerlan","year":"1999","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0235","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jamda.2013.05.009","article-title":"Proinflammatory cytokines, aging, and age-related diseases","volume":"14","author":"Michaud","year":"2013","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0240","first-page":"L1137","article-title":"Elevated IL-15 concentrations in the sarcoidosis lung is independent of granuloma burden and disease phenotypes","volume":"320","author":"Minasyan","year":"2021","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0245","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1084\/jem.20050648","article-title":"The immune paradox of sarcoidosis and regulatory T cells","volume":"203","author":"Miyara","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0250","first-page":"487","article-title":"Intracellular cytokine repertoire in different T cell subsets from patients with sarcoidosis","volume":"56","author":"M\u00f6llers","year":"2001","journal-title":"Thorax."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0255","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12950-015-0066-3","article-title":"Association of serum TNF-\u03b1, IL-8 and free light chain with HLA-DR B alleles expression in pulmonary and extra-pulmonary sarcoidosis","volume":"12","author":"Mortaz","year":"2015","journal-title":"J. Inflamm. (Lond)."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0260","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1164\/ajrccm\/145.1.187","article-title":"Lung-restricted activation of the alveolar macrophage\/monocyte system in pulmonary sarcoidosis","volume":"145","author":"M\u00fcller-Quernheim","year":"1992","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0265","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.alit.2018.02.011","article-title":"TARC expression in the circulation and cutaneous granulomas correlates with disease severity and indicates Th2-mediated progression in patients with sarcoidosis","volume":"67","author":"Nguyen","year":"2018","journal-title":"Allergol. Int."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0270","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2249.2007.03423.x","article-title":"CXCL9 and 11 in patients with pulmonary sarcoidosis: a role of alveolar macrophages","volume":"149","author":"Nishioka","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0275","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.rmed.2007.09.006","article-title":"Circulating levels of both Th1 and Th2 chemokines are elevated in patients with sarcoidosis","volume":"102","author":"Nureki","year":"2008","journal-title":"Respir. Med."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0280","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12974-015-0346-0","article-title":"Pro-inflammatory TNF\u03b1 and IL-1\u03b2 differentially regulate the inflammatory phenotype of brain microvascular endothelial cells","volume":"12","author":"O\u2019Carroll","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2022.577849_bb0285","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.4049\/jimmunol.0903332","article-title":"Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung","volume":"184","author":"Okamoto Yoshida","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0290","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/01902140303786","article-title":"Increased spontaneous interleukin-10 release from alveolar macrophages in active pulmonary sarcoidosis","volume":"29","author":"Oltmanns","year":"2003","journal-title":"Exp. Lung Res."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0295","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/bph.13139","article-title":"Microglial M1\/M2 polarization and metabolic states","volume":"173","author":"Orihuela","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0300","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1378\/chest.09-1003","article-title":"VEGF gene haplotypes are associated with sarcoidosis","volume":"137","author":"Pabst","year":"2010","journal-title":"Chest."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0305","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1755-1536-4-10","article-title":"Immune response CC chemokines CCL2 and CCL5 are associated with pulmonary sarcoidosis","volume":"4","author":"Palchevskiy","year":"2011","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.jneuroim.2022.577849_bb0310","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.trsl.2012.03.005","article-title":"The clinical and immunologic features of pulmonary fibrosis in sarcoidosis","volume":"160","author":"Patterson","year":"2012","journal-title":"Transl. Res."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0315","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1365-2249.2000.01365.x","article-title":"Th1 cytokine pattern in sarcoidosis is expressed by bronchoalveolar CD4+ and CD8+ T cells","volume":"122","author":"Prasse","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0320","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1164\/rccm.201507-1499OC","article-title":"IFN-\u03b3-producing T-helper 17.1 cells are increased in sarcoidosis and are more prevalent than T-helper type 1 cells","volume":"193","author":"Ramstein","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0325","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00281-015-0515-3","article-title":"Control of autoimmune CNS inflammation by astrocytes","volume":"37","author":"Rothhammer","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0330","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejim.2020.04.024","article-title":"Clinical phenotypes and prediction of chronicity in sarcoidosis using cluster analysis in a prospective cohort of 694 patients","volume":"77","author":"Rubio-Rivas","year":"2020","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0335","first-page":"965","article-title":"Sarcoidosis of the spinal cord: literature review and report of eight cases","volume":"98","author":"Saleh","year":"2006","journal-title":"J. Natl. Med. Assoc."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0340","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nri2711","article-title":"The regulation of IL-10 production by immune cells","volume":"10","author":"Saraiva","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0345","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18112306","article-title":"The C-C chemokines CCL17 and CCL22 and their receptor CCR4 in CNS autoimmunity","volume":"18","author":"Scheu","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0350","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00991-2017","article-title":"Phenotypes of organ involvement in sarcoidosis","volume":"51","author":"Schupp","year":"2018","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0355","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00408-003-1028-8","article-title":"Serum vascular endothelial growth factor as a possible prognostic indicator in sarcoidosis","volume":"181","author":"Sekiya","year":"2003","journal-title":"Lung."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0360","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1046\/j.1365-2249.2003.02105.x","article-title":"Increased circulating interleukin-12 (IL-12) p40 in pulmonary sarcoidosis","volume":"132","author":"Shigehara","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0365","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/sj.jcbfm.9600055","article-title":"Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability","volume":"25","author":"Stamatovic","year":"2005","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0370","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.4049\/jimmunol.0903732","article-title":"Differential roles for endothelial ICAM-1, ICAM-2, and VCAM-1 in shear-resistant T cell arrest, polarization, and directed crawling on blood-brain barrier endothelium","volume":"185","author":"Steiner","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0375","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1465-9921-14-121","article-title":"Interferon-inducible chemokines reflect severity and progression in sarcoidosis","volume":"14","author":"Su","year":"2013","journal-title":"Respir. Res."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0380","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/a75007e1-492a-4bcb-80a8-28b4d432c099","article-title":"Significant CD4, CD8, and CD19 lymphopenia in peripheral blood of sarcoidosis patients correlates with severe disease manifestations","volume":"5","author":"Sweiss","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2022.577849_bb0385","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2353\/ajpath.2009.080580","article-title":"FoxP3+ regulatory T cells suppress early stages of granuloma formation but have little impact on sarcoidosis lesions","volume":"174","author":"Taflin","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0390","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1126\/science.7682337","article-title":"Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta","volume":"260","author":"Taub","year":"1993","journal-title":"Science."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0395","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/rheumatology\/ker316","article-title":"Increased IL-17A expression in granulomas and in circulating memory T cells in sarcoidosis","volume":"51","author":"Ten Berge","year":"2012","journal-title":"Rheumatology."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0400","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038083","article-title":"Sarcoidosis and tuberculosis cytokine profiles: indistinguishable in bronchoalveolar lavage but different in blood","volume":"7","author":"Thillai","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2022.577849_bb0405","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/438070","article-title":"Bronchoalveolar lavage fluid IFN-\u03b3+ Th17 cells and regulatory T cells in pulmonary sarcoidosis","volume":"2014","author":"T\u00f8ndell","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0410","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/path.1711700210","article-title":"Identical expression of ELAM-1, VCAM-1, and ICAM-1 in sarcoidosis and usual interstitial pneumonitis","volume":"170","author":"van Dinther-Janssen","year":"1993","journal-title":"J. Pathol."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0415","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/WCO.0000000000000684","article-title":"Management of neurosarcoidosis: a clinical challenge","volume":"32","author":"Voortman","year":"2019","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0420","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1038\/jidsymp.2013.8","article-title":"The biology of IL-15: implications for cancer therapy and the treatment of autoimmune disorders","volume":"16","author":"Waldmann","year":"2013","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0425","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21197398","article-title":"Key players and biomarkers of the adaptive immune system in the pathogenesis of sarcoidosis","volume":"21","author":"Zhou","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0430","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1365-2796.2003.01074.x","article-title":"The cytokine network in sarcoidosis and its clinical relevance","volume":"253","author":"Ziegenhagen","year":"2003","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0435","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1365-2796.2000.00685.x","article-title":"Serum level of soluble tumour necrosis factor receptor II (75 kDa) indicates inflammatory activity of sarcoidosis","volume":"248","author":"Ziegenhagen","year":"2000","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jneuroim.2022.577849_bb0440","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12890-015-0110-3","article-title":"Circulating concentration of markers of angiogenic activity in patients with sarcoidosis and idiopathic pulmonary fibrosis","volume":"15","author":"Ziora","year":"2015","journal-title":"BMC Pulm Med."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572822000443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572822000443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:40:42Z","timestamp":1759048842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572822000443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":88,"alternative-id":["S0165572822000443"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2022.577849","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammatory profiles in plasma and cerebrospinal fluid of patients with neurosarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2022.577849","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"577849"}}